Skip to main content
. 2019 Mar 5;29(3):110–115. doi: 10.2188/jea.JE20170241

Table 1. Patient characteristics and prevalence of comorbidities.

  Gastric cancer Colorectal cancer Lung cancer Weighted score in CCI
Total 1,022 (100) 791 (100) 796 (100)  
All-cause mortality 426 (42) 311 (39) 517 (65)  
Median follow-up duration, days (IQR) 1,460 (451–1,681) 1,520 (708–1,724) 621 (256–1,531)  
Male 706 (69) 420 (53) 542 (68)  
Age at diagnosis        
 <65 years 279 (27) 236 (30) 214 (27)  
 65–69 years 189 (18) 141 (18) 161 (20)  
 70–74 years 205 (20) 133 (17) 160 (20)  
 75–79 years 202 (20) 134 (17) 142 (18)  
 ≥80 years 147 (14) 147 (19) 119 (15)  
Stage at diagnosis        
 Localized 550 (54) 332 (42) 250 (31)  
 Regional to lymph nodes 118 (12) 158 (20) 103 (13)  
 Regional by direct extension 100 (10) 88 (11) 102 (13)  
 Distant 246 (24) 189 (24) 318 (40)  
 Unknown 8 (1) 24 (3) 23 (3)  
Comorbidities        
 Myocardial infarction 5 (0) 8 (1) 10 (1) 0
 Congestive heart failure 22 (2) 14 (2) 27 (3) 2
 Peripheral vascular disease 20 (2) 11 (1) 13 (2) 0
 Cerebrovascular disease 37 (4) 20 (3) 39 (5) 0
 Dementia 7 (1) 12 (2) 7 (1) 2
 Chronic pulmonary disease 33 (3) 19 (2) 59 (7) 1
 Connective tissue disease 2 (0) 2 (0) 2 (0) 1
 Peptic ulcer 266 (26) 75 (9) 35 (4) 0
 Mild liver disease 51 (5) 42 (5) 43 (5) 2
 Moderate or severe liver disease 4 (0) 1 (0) 1 (0) 4
 DM without chronic complications 106 (10) 72 (9) 84 (11) 0
 DM with chronic complications 11 (1) 22 (3) 19 (2) 1
 Hemiplegia or paraplegia 1 (0) 1 (0) 0 (0) 2
 Renal disease 13 (1) 7 (1) 3 (0) 1
 Other cancer 79 (8) 59 (7) 73 (9) 2
 AIDS or HIV 0 (0) 0 (0) 0 (0) 4

AIDS, acquired immunodeficiency syndrome; DM, diabetes mellitus; HIV, human immunodeficiency virus; IQR, interquartile range.

Values are expressed as number (column percentage) unless otherwise indicated. Because of rounding, percentages may not add up to 100%.